DOYLE MITTIE (Chief Medical Officer) reported 1 transaction at AVALO THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/12/2026ACC: 0001918845-26-000018
Officer· Chief Medical Officer
Since Feb 2026
-1.08K
Net shares
Net seller
$14.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.08K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.08K
Price / share
$13.10
Trade value
$14.20K
% of position
2.1%
6/10/2026
52.86K→51.78K
Total
Net shares
−1.08K
Net value
-$14.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/10/2026 | F · Tax Withholding | −1.08K | $13.10 | $14.20K | 2.1% | 52.86K | 51.78K |
| Total | −1.08K | -$14.20K | ||||||
Derivative Transactions0
No derivative transactions reported